CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10,568 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01171404
NCT01171404N/ACompleted

Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients

AstraZeneca·observational·Posted Jul 28, 2010·Updated Apr 17, 2013

In Brief

An observational study for ACS and 4 related conditions. Completed, enrolled 10,568 participants across 410 sites in 20 countries.

Detailed Summary

The aim of this international study is to describe the short- and long-term (i.e. up to 2 years following the index event) antithrombotic management patterns (AMPs) in patients hospitalized for acute coronary syndromes (ST segment elevation myocardial infarction (STEMI), Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS)), and to document the impact of AMPs in clinical outcomes, economic variables and quality of life in a 'real-life' setting and to compare these between sites, countries and regions.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesArgentina, Belgium, Brazil, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Mexico, Netherlands, Norway, Poland, Romania, Slovenia, Spain, Turkey (Türkiye), United Kingdom, Venezuela
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 28, 2010
Enrollment StartSep 1, 2010
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 15.9 years ago